# First Drug to Fix Genetic Obesity's Root Cause Enters Human Trials - Date: 2026-03-20 - Category: Biotech & Life Sciences Clarissa Desjardins's new company has dosed its first subjects in a Phase 1 trial of an oral genetic obesity drug — a pharmacological corrector that takes a fundamentally different approach from GLP-1 agonists. ---